How bariatric and metabolic operations control metabolic syndrome

British Journal of Surgery

Volumn 98, Issue 10, 2011, Pages 1339-1341

  Ikramuddin, S ^a   Buchwald, H ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BARIATRIC SURGERY; DYSLIPIDEMIA; HUMAN; HYPERTENSION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; WEIGHT REDUCTION;

BARIATRIC SURGERY; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; HUMANS; HYPERTENSION; METABOLIC SYNDROME X; WEIGHT LOSS;

EID: 80052407079     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7652     Document Type: Article

References (19)

1. Buchwald H, Varco RL, (eds). Metabolic Surgery. Grune and Stratton: New York, 1978.
2. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al., Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-1737.
3. Berthoud H-R, Neuhuber WL,. Functional and chemical anatomy of the afferent vagal system. Auton Neurosci 2000; 85: 1-17.
4. Whitson BA, Leslie DB, Kellogg TA, Maddaus MA, Buchwald H, Billington CJ, et al., Entero-endocrine changes after gastric bypass in diabetic and nondiabetic patients: a preliminary study. J Surg Res 2007; 141: 31-39.
5. Brookes SJH, Costa M,. Cellular organization of the mammalian enteric nervous system. In Innervation of the Gastrointestinal Tract, Brookes S, Costa M, (eds). Taylor & Frances: London, 2002; 393-467.
6. Scopinaro N, Gianetta E, Friedman D, Adami GF, Traverso E, Bachi V,. Evolution of biliopancreatic bypass. Clin Nutr 1986; 5 (Suppl): 137-146.
7. Pories WJ, Swanson MS, MacDonald KG, Long SB, Morris PG, Brown BM, et al., Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg 1995; 232: 339-350.
8. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories W, et al., Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122: 248-256.
9. Rubino F, Marescaux J,. Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease. Ann Surg 2004; 239: 1-11.
10. 2: a report of 2 cases. Surg Obes Rel Dis 2007; 3: 195-197.
11. Bohdjalian A, Prager G, Aviv R, Policker S, Schindler K, Kretschmer S, et al., One-year experience with Tantalus: a new surgical approach to treat morbid obesity. Obes Surg 2006; 16: 627-634.
12. Drucker DJ, Nauck MA,. The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes. Lancet 2006; 368: 1696-1705.
13. Mingrone G, Castagneto-Gissey L,. Mechanisms of early improvement/resolution of type 2 diabetes after bariatric surgery. Diabetes Metab 2009; 35: 518-523.
14. Sjöström L, Lindroos AK, Peltonen M, Torgerson J, Bouchard C, Carlsson B, et al.,; Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004; 351: 2683-2693.
15. Buchwald H, Varco RL, Matts JP, Long JM, Fitch LL, Campbell GS, et al., Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH). N Engl J Med 1990; 323: 946-955.
16. Buchwald H, Moore RB, Varco RL,. Surgical treatment of hyperlipidemias. I (Apologia). II (The laboratory experience). 3 (Clinical status of the partial ileal bypass operation). Circulation 1974; 49: Il-I37.
17. Greco AV, Mingrone G, Giancaterini A, Manco M, Morroni M, Cinti S, et al., Insulin resistance in morbid obesity: reversal with intramyocellular fat depletion. Diabetes 2002; 51: 144-151.
18. Taylor R,. Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause. Diabetologia 2008; 51: 1781-1789.
19. Frezza EE, Wei C, Wachtel MS,. Is surgery the next answer to treat obesity-related hypertension? J Clin Hypertens 2009; 11: 284-288.